Shroff, R. T., Yarchoan, M., O'Connor, A., Gallagher, D., Zahurak, M. L., Rosner, G., . . . Azad, N. S. (2017). The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma. Br J Cancer.
Style de citation ChicagoShroff, Rachna T., et al. "The Oral VEGF Receptor Tyrosine Kinase Inhibitor Pazopanib in Combination With the MEK Inhibitor Trametinib in Advanced Cholangiocarcinoma." Br J Cancer 2017.
Style de citation MLAShroff, Rachna T., et al. "The Oral VEGF Receptor Tyrosine Kinase Inhibitor Pazopanib in Combination With the MEK Inhibitor Trametinib in Advanced Cholangiocarcinoma." Br J Cancer 2017.
Attention : ces citations peuvent ne pas être correctes à 100%.